Download Duramune® Lyme™+Max 5-CvK - Boehringer Ingelheim Vetmedica

Duramune® Lyme™+Max 5-CvK
(The PuppyShot®+Duramune® Lyme™)
Formerly Duramune® Max 5-CvK+LymeVax®
Description
Duramune Lyme+Max 5-CvK is a canine combination vaccine containing six antigens including modified-live distemper, adenovirus 2,
parvovirus 2b, and parainfluenza. It also includes inactivated (killed) coronavirus and Borrelia burgdorferi.
Advantages
Features
Benefits
Fewer injections
• Multiple antigens bundled into a single vaccine
• Saves time
• H
elps streamline your vaccine
protocol
• S
pares your patients multiple
injections
• Lower cost compared with the cost of multiple vaccines
Cost effective
Proven safety and efficacy1-6
Lyme antigen:
• Backed by rigorous field research1-6
• 100 percent preventable fraction in a challenge study
conducted recently for USDA requalification1
• Proven 92 percent effective against natural infection in a
one-of-a-kind study conducted on real-world dogs in a highly
endemic area2 — unprecedented proven efficacy among canine
Lyme vaccines
Indications
For subcutaneous vaccination of healthy
dogs 9 weeks of age or older as an aid
in the prevention of disease caused
by canine distemper, infectious canine
hepatitis, canine adenovirus type 2, canine
coronavirus, canine parainfluenza, canine
parvovirus and Borrelia burgdorferi.
All dogs over 12 weeks of age should initially
receive one dose of this product and a second
dose two to three weeks later.
Dosage & Administration
Aseptically rehydrate DURAMUNE MAX 5
with canine coronavirus vaccine-Borrelia
burgdorferi bacterin supplied.
SHAKE WELL.
Gentamicin and thimerosal added
as preservatives.
For healthy dogs 9 weeks of age or older,
administer one 1-mL dose subcutaneously.
Caution
In case of an anaphylactoid reaction,
administer epinephrine. Burn container
and all unused contents.
For veterinary use only.
Storage Information
Store in the dark at 2º to 7º C (35º to
45º F). AVOID FREEZING.
The presence of maternal antibody is known
to interfere with the development of active
immunity. Puppies should be revaccinated
every two to three weeks until 12 weeks
of age.
• S
avings compared with the cost of
multiple vaccines
• G
ives your patients safe, reliable
protection from canine Lyme disease
Product Information
Name
Duramune® Lyme™+Max 5-CvK
(The PuppyShot®+Duramune® Lyme™)
Code
18215C
Size
25 x 1-mL vials of vaccine plus 25 x 1-mL
vials of diluent
Boehringer Ingelheim Vetmedica, Inc.
2621 North Belt Highway
St. Joseph, MO 64506-2002
Information 1-866-638-2226
Sales Service 1-800-325-9167
Fax 1-800-318-8366
www.BI-Vetmedica.com
www.lymeinfo.com
USDA Requalification Study, 2007.
1
Levy S. Use of a C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of
naturally transmitted canine Borrelia burgdorferi infection. Vet Ther. 2002;3(4):420-424.
2
Chu HJ, Chavez LG, Blumer BM, et al. Immunogenicity and efficacy study of a commercial Borrelia
burgdorferi bacterin. JAVMA. 1992;201(3):403-411.
3
Levy SA, Lissman BA, Ficke CM. Performance of a Borrelia burgdorferi bacterin in borreliosisendemic areas. JAVMA. 1993;202(11):1834-1838.
4
Guerra MA, Walker ED, Kitron J. Quantitative approach for the serodiagnosis of canine Lyme disease
by the immunoblot procedure. J Clin Microbiol. 2000;38(7):2628-2632.
5
Moore GE, Guptill LF, Ward MP, et al. Adverse events diagnosed within three days of vaccine
administration in dogs. JAVMA. 2005;38(7):1102-1108.
6
All trademarks are owned by their manufacturers.
©2010 Boehringer Ingelheim Vetmedica, Inc.
CAN0510006